Eco-Friendly inhaler on the horizon? new study checks if it works the same
NCT ID NCT06139991
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a new, more environmentally friendly propellant (HFO) in a budesonide/albuterol inhaler delivers the same amount of medicine into the bloodstream as the current version (HFA). Sixty-six healthy adults received single doses of both inhalers in a random order. The goal was to see if the drug levels were similar enough to consider the two versions equivalent.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- budesonide and albuterol (inhaler with a new propellant)
- What this could lead to
- If successful, this could confirm that the new propellant version of the inhaler works the same as the current one, potentially leading to a more environmentally friendly option.
- What could go wrong
- This is a very early, small study in healthy people, not patients. It only checks drug levels in the blood, not whether the inhaler actually treats asthma or COPD. The new propellant might still behave differently in real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEATHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Glendale, California, 91206, United States